Objective To investigate the effect of electromyographic biofeedback therapy on upper extremity function in children with cerebral palsy(CP).Methods 20 CP children were randomly divided into the treatment group and control group with 10 cases in each group.All children of two groups were treated with Bobath therapy and regularly training of activities of daily living(ADL),physical therapy and occupational therapy,while those of the treatment group were given electromyographic biofeedback therapy with EMG-electrical stimulation.The active range of motion(AROM)of wrist dorsiflexion was evaluated and upper extremity function was assessed by Fugl-Meyer Assessment(FMA).Results The upper extremity function of all children in two groups improved and the effect of the children of the treatment group were superior to those of the control group(P<0.05).Conclusion The electromyographic biofeedback therapy with EMG-electrical stimulation can improve the upper extremity function of CP children.

Objective:To evaluate the efficacy and safety of dl-3-butylphthalide ( NBP) injection and soft capsules in the treat-ment of acute middle cerebral artery infarction. Methods:Sixty-one patients with acute cerebral infarction in the left middle cerebral artery in 72 hours of onset of ischemic stroke with score of 5-25 according to the national institutes of health stroke scale ( NIHSS) were randomly divided into the observation group (n=31) and the control group (n=30). The control group was treated with the routine treatment, while the observation group was sequentially treated with NBP injection and soft capsules additionally. The treatment course was 90 days. Before the treatment, the NIHSS score was evaluated in both groups to compare the neurologic impairment degree. After the treatment, the daily living skills assessment was performed by Barthel index ( BI) and modified Rankin score ( mRS) , and the ad-verse reactions were recorded. Results:Before the treatment, the NIHSS score in the two groups had no statistical significance ( P>0. 05). After the treatment, the BI in the observation group and the control group was (88. 55 ± 16. 74) and (70. 67 ± 26. 18), and mRS was (1. 87 ± 1. 02) and (2. 53 ± 1. 40), respectively, suggesting the observation group had more favorable outcome than the con-trol group (P≤0. 05). The incidence of adverse reactions had no significant difference between the groups. Conclusion: dl-3-Bu-tylphthalide sequential therapy should be regarded as an effective and safe method for acute cerebral infarction, which can improve the daily living skills and 90-day outcome of patients.